thembcthembchttps://www.thembc.org.au/news-oldAnd the award goes to....our Epilepsy team!]]>https://www.thembc.org.au/single-post/2015/09/14/And-the-award-goes-toour-Epilepsy-teamhttps://www.thembc.org.au/single-post/2015/09/14/And-the-award-goes-toour-Epilepsy-teamMon, 14 Sep 2015 04:54:39 +0000
Most of our epilepsy researchers attended the the International Epilepsy Conference in Instabul recently.
Two of our researchers received awards:
Congratulations to our PhD student, Dr. Ping Zheng, who was awarded the 2015 Harinarayan Young Neuroscientist Award by the International League Against Epilepsy. A big congratulations also to Professor Frank Vajda, Professorial Fellow and Neurologist, who received an Ambassador for Epilepsy Award.
]]>MS @MBC - kicking goals!]]>https://www.thembc.org.au/single-post/2015/09/14/MS-MBC-kicking-goalshttps://www.thembc.org.au/single-post/2015/09/14/MS-MBC-kicking-goalsMon, 14 Sep 2015 04:48:54 +0000
Our MS researchers have ask been very busy. The team has recently published two papers and completed 3 other major projects:
Publications
1. Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova
E, Horakova D, et al., on behalf of the MSBase Study Group (in press) Defining reliable disability outcomes in multiple sclerosis. Brain, accepted 11/07/2015
This paper evaluated disability endpoints commonly used in clinical trials, and has a potential to influence the design of future trials in MS.
2. Warrender-Sparkes M, Spelman T, Izquierdo G, ... Kalincik T* and Jokubaitis V*, on behalf of the MSBase Study Group (in press) The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. Mult Scler, accepted 27/05/2015
Projects
Two of our student MS researchers, Tamasine Stewart and Nathaniel Lizak have recently completed their projects: Tamasine showed that the impact of relapses on accumulation of permanent neurological disability depends on the clinical presentation of relapses. Nathaniel demonstrated that progressive disability in moderately and severely advanced multiple sclerosis can be modified with disease modifying therapy, an observation with a potential impact on the clinical management of MS globally. The resulting research papers are currently under review.
Our visiting fellow, Dr Johannes Lorscheider from Switzerland has just completed a project which is the first comprehensive study to establish an objective definition of secondary progressive MS.
]]>Launch of Epilepsy Week]]>https://www.thembc.org.au/single-post/2015/09/07/Launch-of-Epilepsy-Weekhttps://www.thembc.org.au/single-post/2015/09/07/Launch-of-Epilepsy-WeekMon, 07 Sep 2015 04:35:00 +0000
"Third time's a charm" - join us for another MBC-RMH feature week! This time our epilepsy researchers step in fornt of the camera to talk about their work and the clinical trials we have active at our Centre.
Stay tuned and checkout the updates on our facebook page or ask our Epileptologists a few tough question on the BRAINtranslate Forum:
http://www.braintranslate.org.au/